Resistência a antibióticos | É precisa vontade política proporcional à urgência
Sabemos muito bem e há muito tempo o que a resistência antimicrobiana precisa: financiamento, recursos humanos qualificados e formação na prevenção de infeções, em microbiologia e no uso racional d...
Learn how the European Medicines Agency's PRIME (PRIority MEdicines) scheme helps accelerate the development of promising medicines for patients with unmet medical needs.
In this video, Kevin Cunn...
Learn how the European Medicines Agency's PRIME (PRIority MEdicines) scheme helps accelerate the development of promising medicines for patients with unmet medical needs.
In this video, Kevin Cunn...
Equitable Access to Medical Tools for Bundibugyo Ebola
The Bundibugyo Ebola outbreak highlights a persistent gap: medical tools for diseases affecting low- and middle-income countries are still not prioritised, funded, or made accessible quickly enough...
Faltan muchos medicamentos vitales 😢
🧒👶¿Qué sucede si un niño no tiene hierro en pleno desarrollo?
♋¿Qué pasa si una persona con cáncer no puede acceder al tratamiento que necesita?
En los campam
Corinne de Vries, EMA lead on medicines in pregnancy and breastfeeding, explains how better safety data can be generated at every stage of a medicine’s lifecycle.
...proaches to clinical research have contributed to the lack of data and why it’s essential to rethink the inclusion of pregnant and breastfeeding individuals in clinical trials.
C...
This is Part 2 of The Original Blueprint, our Oceans Month mini-series where we look past the surface to find the mind-blowing ways the sea keeps humanity alive. Today we’re exploring the deep ocea...
Lenacapavir: A gamechanger in HIV prevention, but out of reach
Lenacapavir, or LEN, is a gamechanging HIV prevention injection given just twice a year and shown to be nearly 100% effective.
But Gilead is keeping LEN out of reach for many people in low- and mi...
Bridging sectors for global health impact | One Dose, One Cure
🛖 In remote communities affected by sleeping sickness, reaching patients isn’t easy. As Trevor Mundel, President of Global Health at the Gates Foundation, says: ‘People in remote regions, you only ..
From loss to hope: Mbo's message to sleeping sickness patients | One Dose, One Cure
💊 Today, hope is growing for people like Mbo. The Democratic Republic of the Congo (DRC) has approved acoziborole, a single-dose oral treatment for sleeping sickness!
Mbo is a living testament to ..
This #Ebola disease outbreak once again exposes persistent failures to ensure that accessible medical tools for diseases disproportionately affecting low- and middle-income countries are prioritise...
Briefing Session: Innovative Financing Instrument for Access to High-Price Medicines through the PAHO Regional Revolving Funds and the IDB
When people think of Bangladesh’s exports, garments usually come to mind. But there’s another quiet success story: its pharmaceutical industry. Medicines made in Bangladesh are reaching patients in...
...ear-old delivery driver from Skopje, North Macedonia, whose struggle to pay for essential medicines reflects a broader challenge across the Western Balkans. For years, Marko relie...
From common antibiotics to emergency room drugs, the key ingredients for many life-saving medicines in the United States come directly from China, creating a dangerous vulnerability. China can impo...
Out-of-pocket payments for medicines are the main drivers of “catastrophic health spending”—that is when people can’t afford meeting basic needs like food, housing or heating. As Boris, 65, says, “...
Marjik lives with diabetes. One of the 1.3 million people in Armenia living with diabetes and other non-communicable diseases, she has struggled to afford her medications. Now, thanks to a major he...
New innovations to accelerate malaria elimination in a complex world
As malaria becomes more complex, treatment and prevention tools must become simpler.
Progress against malaria has stalled. Meanwhile, drug resistance is rising, and climate change and conflict are...